Canopy Growth (CGC) Depreciation & Amortization (CF) (2019 - 2025)

Canopy Growth (CGC) reported Depreciation & Amortization (CF) of $10.2 million for Q4 2025, up 232.85% on a YoY basis from $3.1 million in Q4 2024, and up 234.92% sequentially from $3.1 million in Q3 2025.

Canopy Growth (CGC) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends

Canopy Growth (CGC) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $10.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 232.85% year-over-year to $10.2 million; the trailing twelve-month figure through Mar 2026 stood at $16.7 million (up 61.39% YoY), and the FY2026 full-year result was $13.9 million, down 7.5% from the prior year.
  • Depreciation & Amortization (CF) climbed to $10.2 million in Q4 2025, from $3.1 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $15.5 million in Q1 2022 to a low of $3.1 million in Q3 2025.
  • A 5-year average of $7.6 million and a median of $8.0 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • Across the five-year window, Depreciation & Amortization (CF) slumped 56.41% in 2023 and surged 232.85% in 2025, its largest moves.
  • Tracing CGC's Depreciation & Amortization (CF) over 5 years: stood at $4.4 million in 2021, then jumped by 94.41% to $8.6 million in 2022, then tumbled by 56.28% to $3.7 million in 2023, then slipped by 17.72% to $3.1 million in 2024, then surged by 232.85% to $10.2 million in 2025.
  • Business Quant data shows CGC's Depreciation & Amortization (CF) at $10.2 million in Q4 2025, $3.1 million in Q3 2025, and $3.4 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Canopy Growth 197.77 Mn -68.15 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 10.24 Mn
Dec 31, 2025 10.24 Mn
Sep 30, 2025 3.06 Mn
Sep 30, 2025 3.06 Mn
Jun 30, 2025 3.43 Mn
Jun 30, 2025 3.43 Mn
Dec 31, 2024 3.08 Mn
Dec 31, 2024 3.08 Mn
Sep 30, 2024 3.13 Mn
Sep 30, 2024 3.13 Mn
Jun 30, 2024 4.15 Mn
Jun 30, 2024 4.15 Mn
Mar 31, 2024 4.37 Mn
Mar 31, 2024 4.37 Mn
Dec 31, 2023 3.74 Mn
Dec 31, 2023 3.74 Mn
Sep 30, 2023 3.78 Mn
Sep 30, 2023 3.78 Mn
Jun 30, 2023 7.96 Mn
Jun 30, 2023 7.96 Mn